Stratified meta-analysis for treatment duration effects of statins versus placebo subdivided into 3-4 months and longer than 4 months of treatment for حسب Solima Sabeel (9545738)

الموضوعات:

Reason for exclusion of all 6514 screened articles. حسب Solima Sabeel (9545738)

الموضوعات:

Methodological items for non-randomized studies (MINORS). حسب Solima Sabeel (9545738)

الموضوعات:

Jadad Score of randomized controlled trials. حسب Solima Sabeel (9545738)

الموضوعات:

Summary of randomized controlled trials. حسب Solima Sabeel (9545738)

الموضوعات:

LDL-C meta-analysis showing in (A) the overall effects of different statin types versus placebo and (B) stratified by statin treatment duration for 3-4 months and longer than 4 mon... حسب Solima Sabeel (9545738)

الموضوعات:

Overall analysis of randomized controlled trials. حسب Solima Sabeel (9545738)

الموضوعات:

Summary table showing analysis of randomized controlled trials stratified based on age groups. حسب Solima Sabeel (9545738)

الموضوعات:

Meta-analysis showing the overall effect of different statin types versus placebo for حسب Solima Sabeel (9545738)

الموضوعات:

Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. حسب Solima Sabeel (9545738)

الموضوعات:

Analysis of randomized controlled trials stratified based on treatment duration. حسب Solima Sabeel (9545738)

الموضوعات:

Funnel plots of studies included in the meta-analysis assessing حسب Solima Sabeel (9545738)

الموضوعات:

Summary of non-randomized studies. حسب Solima Sabeel (9545738)

الموضوعات:

PRISMA flow diagram of the systematic literature search process. حسب Solima Sabeel (9545738)

الموضوعات:

Newcastle-Ottawa scale. حسب Solima Sabeel (9545738)

الموضوعات:

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"